Target:
|
Bcl-XL
|
Target Alias Names:
|
BCL2L1 phospho T47, BCL2L1 phospho Thr47, p-BCL2L1 phospho T47, p-BCL2L1 Thr47, p-BCL2L1Thr115, Apoptosis regulator Bcl X, BclX, Bcl-X, Bcl 2 like 1, Bcl 2 like 1 protein, Bcl xL, BCL X/L, BCL XL/S, Bcl xS, Bcl2 like1, BCL2-related gene, BCL2-related protein, long isoform, included, BCLXL, included, BCL2-related protein, short isoform, included, BCLXS, included, BCL2L, BCL2L1, Bclx, DKFZp781P2092, MGC113803, MGC99998, B2CL1_HUMAN.
|
Species Reactivity:
|
Human, Mouse, Rat
|
Applications:
|
Immunohistochemistry, Western Blot
|
Type:
|
Primary Recombinant
|
Isotype/Mimetic:
|
IgG
|
Host Species:
|
Rabbit
|
Conjugates:
|
Cy3, Cy5, Cy5.5, Cy7, FITC, PE, Biotin, HRP, BF350, BF405, BF555, BF594, BF647, BF680, BF750, APC, APC-Cy5.5, APC-Cy7, PE-Cy5, PE-Cy5.5, PE-Cy7, PerCP, PerCP-Cy5.5, RBITC
|
Formulation:
|
0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
|
Animal-Derived Biomaterials Used:
|
BSA
|
Sequence Available
|
No
|
Original Discovery Method
|
Naïve display libraries from animal B cells
|
Original Discovery Information Provided On Datasheet
|
No
|
Antibody/Binder Origins:
|
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation
|